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Abstract (121/150 words) 
 
 Variants in the neuronal sodium channel gene SCN8A have been implicated in several 
neurological disorders. Early infantile epileptic encephalopathy type 13 results from de novo 
gain-of-function mutations that alter the biophysical properties of the channel. Complete loss-
of-function variants of SCN8A have been identified in cases of isolated intellectual disability. 
We now report a novel heterozygous SCN8A variant, p.Pro1719Arg in a small pedigree with 
five family members affected with autosomal dominant upper limb isolated myoclonus 
without seizures or cognitive impairment. Functional analysis of the p.Pro1719Arg variant in 
transfected neuron-derived cells demonstrated greatly reduced Nav1.6 channel activity 
without altered gating properties. Hypomorphic alleles of Scn8a in the mouse are known to 
result in similar movement disorders. This study expands the phenotypic and functional 
spectrum of SCN8A variants to include inherited non-epileptic isolated myoclonus. SCN8A 
can be considered as a candidate gene for isolated movement disorders without seizures.  
 
Key Words: sodium channel, movement disorder, myoclonus, Nav1.6  
 
 
 The SCN8A gene (MIM# 600702) encodes the neuronal voltage-gated sodium channel 
Nav1.6, which is localized at the axon initial segment and functions in initiation and 
propagation of action potentials. Nav1.6 is also concentrated at nodes of Ranvier in 
myelinated neurons, including sciatic nerve, and is expressed at a high level in cerebellar 
Purkinje cells. During the past 5 years, SCN8A has been found to have a major role in 
sporadic epilepsy. De novo missense mutations of SCN8A have been identified in more than 
200 individuals with early-onset epileptic encephalopathy (EIEE13; MIM# 614558).  
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Approximately 25% of affected individuals carry recurrent mutations, many of which occur at CpG 
dinucleotides in arginine codons (Wagnon & Meisler, 2015).  Functional analysis has demonstrated 
that the most common mechanism is gain-of-function alterations in biophysical properties of Nav1.6 
that result in neuronal hyperexcitability (Meisler et al., 2016; Veeramah et al., 2012).. A small 
number of inherited variants have been associated with less severe conditions, including 
benign familial infantile seizures accompanied by paroxysmal dyskinesia (BFIS5, OMIM 
#617080) (Anand et al., 2016; Butler et al., 2017; Gardella et al., 2016; Han, Jang, Lee, Shin, 
& Park, 2017).  Heterozygous loss-of-function mutations of SCN8A have been associated 
with isolated cognitive impairment in two individuals with de novo mutations (Wagnon et al., 
2017) and one family with the protein truncation variant p.Pro1719Argfs*6 (OMIM 
#614306). In the mouse, homozygosity for partial loss-of-function alleles of Scn8a results in 
movement disorders including ataxia, tremor, and dystonia, while homozygosity for null 
alleles results in paralysis and juvenile lethality (Kearney et al., 2002; O'Brien & Meisler, 
2013).  
 We now describe a missense variant of SCN8A in a family with non-epileptic 
essential myoclonus. The proband is a 35-year-old female with onset of essential myoclonus 
at age 5 (Figure 1A, II-2). She was diagnosed with upper limb action-induced non-epileptic 
myoclonus, part of the myoclonus-dystonia spectrum (MIM# 159900). The myoclonus is 
alcohol-responsive in this individual. The proband has normal cognition and no other 
neurological abnormalities including dystonic posturing. Her affected nephew (Figure 1A, 
III-2) is a 7-year-old male with onset of action-induced myoclonus in the upper limbs at age 
4, and evidence of subcortical origin from electrophysiological studies. EMG recordings in the 
upper limbs showed irregular, multifocal, myoclonic bursts, with duration ranging from 50 to 200 
msec. Myoclonic jerk frequency was  increased with maintenance of a posture or with action. EEG 
back-averaging did not reveal a cortical correlate. His motor milestones were delayed, e.g. 
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independent walking at age three, but he does not have intellectual disability and does not 
exhibit dystonia or other neurological abnormalities. The clinical features of these two family 
members are summarized in Supplemental Table 1.   Three additional family members were 
reported as affected by a similar movement disorder (Figure 1A, I-2, II-3, and III-1), but 
were not examined directly. The pedigree is consistent with autosomal dominant inheritance.  
 In order to identify the genetic basis for the disorder, we performed whole-exome 
sequencing (WES) in individuals II-2 and III-2. The study was approved by the University 
College London ethics committee (UCLH project 06/N076), and written informed consent 
was obtained from all participating subjects. DNA was extracted from peripheral 
lymphocytes following a standard protocol. Point mutations and copy-number variants in 
SGCE, the most common genetic cause of autosomal dominant myoclonus-dystonia (OMIM 
#159900), were previously excluded (Carecchio et al., 2013).  
 WES was carried out at the Institute of Neurology, University College London, using 
Illumina’s Nextera Rapid Capture according to the manufacturer’s recommendations. 
Indexed and pooled libraries were sequenced on Illumina’s HiSeq3000. Bioinformatic 
analysis was performed as previously described (Mencacci et al., 2015). 
  Synonymous and non-coding variants were excluded from further examination. 
Variants were filtered to include only those that were shared by the two affected individuals 
and absent from public genomic databases (dbSNP 137, 1000 Genomes project, NHLBI 
Exome Variant Server, Complete Genomics 69 and Exome Aggregation Consortium 
[ExAC]). Finally, variants were required to have a CADD score greater than 20, indicative of 
greater potential for pathogenicity (http://cadd.gs.washington.edu/info) (Kircher et al., 2014).  
 After filtering, 11 variants remained (Supplemental Table 2). Among these, SCN8A 
is the only gene with previous association with movement disorders and a high intolerance 
score for missense and loss-of-function variants (z=7.7 and pLI=1.0) 
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(exac.broadinstitute.org).  Sanger sequencing analysis showed that the SCN8A mutation was 
also present in individual III-1 (Figure 1A). 
  Affected individuals are heterozygous for the single nucleotide variant c.5156C>G in 
the SCN8A gene (RefSeq NM_014191.3), resulting in the amino acid substitution 
p.Pro1719Arg (P1719R). This variant is absent in ~130,000 individuals listed in the gnomAD 
database (http://gnomad.broadinstitute.org).  Proline residue 1719 is located in the pore loop 
of domain IV of the protein that confers sodium selectivity to the channel (Figure 1B). The 
pore loops are highly conserved through evolution and SCN8A residue 1719 is invariant in 
vertebrate orthologs and the human paralogs SCN1A and SCN5A, which diverged from 
SCN8A more than 400 million years ago (Figure 1C).  Substitution of a charged arginine for 
the rigid proline residue is a chemically nonconservative change likely to alter secondary 
structure of the channel protein. This variant has been submitted as entry # 00163785 to the 
locus specific public database http://www.lovd.nl/SCN8A. 
 To determine experimentally whether P1719R is a deleterious variant, we carried out 
functional comparison of mutant and wildtype Nav1.6. The substitution P1719R was 
introduced into the tetrodotoxin (TTX)-resistant derivative of the full-length Nav1.6 cDNA 
clone, as previously described (Wagnon et al., 2016). Site-directed mutagenesis was carried 
out with the QuikChange II XL kit (Agilent Technologies). The 6-kb open reading frame was 
re-sequenced to confirm the absence of other mutations. 
 Channel activity was characterized in DRG-neuron derived ND7/23 cells (Sigma 
Aldrich). Cells were cultured and transfected as previously described (Wagnon et al., 2016). 
Forty-eight hours after transfection with 5 μg of Nav1.6 alpha subunit cDNA and 0.5 μg of 
the fluorescent m-Venus bioreporter, electrophysiological recordings of fluorescent cells 
were made. Recording was carried out in the presence of 500 nM tetrodotoxin (TTX) to 
block endogenous sodium currents. Currents were recorded using the whole-cell 
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configuration of the patch clamp recording technique as previously described (Wagnon et al., 
2016).  
 Cells expressing the Nav1.6-P1719R variant demonstrated inward sodium current that 
was significantly reduced compared to cells expressing wildtype channels: -27.3 ± 5.3 pA/pF 
(n=9) for mutant channel compared with -108 ± 21 pA/pF (n=9) for wild-type channel 
(p<0.01) (Figure 2 A, B). The voltage dependence of mutant channel activation and 
inactivation did not differ from wildtype (Figure 2, C-F). The finding of partially reduced 
channel activity for P1719R is novel, since previously characterized deleterious variants 
resulted either in shifted voltage dependence of activation (Estacion et al., 2014), delayed 
channel inactivation (Wagnon et al., 2016), or complete loss of channel activity (Wagnon et 
al., 2017).  
 Individuals with epileptic encephalopathy due to gain-of-function mutations of 
SCN8A often exhibit movement disorders and other neurological signs such as hypotonia, 
ataxia, dystonia, hyperreflexia and choreoathetosis (Meisler et al., 2016). Severe hypotonia in 
these individuals is responsible for loss of intentional movement in 50% of cases (Meisler et 
al., 2016). SCN8A variants have not been previously reported in individuals with isolated 
movement disorders.  This absence may reflect the lack of sequencing data in this population 
or the failure to recognize the relevance of missense variants. The identification of SCN8A-
P1917R co-segregating with isolated non-epileptic myoclonus demonstrates that mutation of 
SCN8A can result in isolated movement disorders in patients. 
 Variants of SCN8A with gain-of-function and elevated channel activity, either due to 
premature channel opening or delayed channel closing, result in epileptic encephalopathy 
(Meisler et al, 2016). At the other extreme, heterozygosity for complete loss-of-function 
alleles  of SCN8A can result in  isolated intellectual disability (Trudeau, Dalton, Day, Ranum, 
& Meisler, 2006; Wagnon et al., 2017). In rare cases, seizures have been seen in individuals 
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with loss-of-function alleles of SCN8A lacking residual activity (Blanchard et al., 2015; 
Moller et al., 2016). Partial loss-of-function with residual activity, as demonstrated here for 
P1719R, has not previously been described for a pathogenic variant of human SCN8A.  The 
dominant phenotype of this pore loop mutation could result from impaired trafficking of the co-
expressed wildtype type Nav1.6, possible because of the recently described dimerization of the  
subunit (Clatot et al, 2017).  As another possibility, this mutation could impair glycosylation or 
trafficking of the channel protein (e.g. Jones et al., 2016).  The data presented here demonstrate that 
heterozygosity for partial loss-of-function of SCN8A can be associated with movement disorders 
without seizures. 
 In the mouse, homozygosity for the hypomorphic Scn8a
medJ
 allele, a splice site variant 
with 90% reduction in Nav1.6 protein, results in severe progressive dystonia (Sprunger, 
Escayg, Tallaksen-Greene, Albin, & Meisler, 1999). A second hypomorphic allele, Scn8a
9J
, 
results in early onset tremor and adult onset dystonia (Jones et al., 2016). Complete loss of 
mouse Scn8a associated with homozygosity for a null allele results in hind limb paralysis and 
death (Burgess et al., 1995).  Conditional inactivation of Scn8a restricted to cerebellar 
Purkinje and granule layer neurons also leads to pronounced ataxia (Levin et al., 2006), and 
dysfunction of cerebellar neurons could contribute to myoclonus in the family described here. 
Cerebellum dysfunction has been implicated in the pathogenesis of other forms of non-
epileptic myoclonus such as SGCE-related myoclonus-dystonia (Carbon et al., 2013; Hubsch 
et al., 2011). Furthermore, we observed improvement of myoclonus with alcohol intake in the 
adult subject with SCN8A-P1719R, an effect likely to occur through modulation of the 
activity of cerebellar neurons.   
 Three affected family members were demonstrated to carry the SCN8A variant.  A 
fourth affected family member, II-3, is an obligate carrier since his sister and son carry the 
variant. The fifth affected individual, III-1, who was not available for testing, is likely to 
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carry this variant since her clinical symptoms correspond to the other four affected family 
members. SCN8A-P1719R thus appears to be a fully penetrant pathogenic variant responsible 
for autosomal dominant isolated myoclonus in this family, with no evidence of maternal 
imprinting as observed in myoclonus dystonia due to mutations of SGCE.  In distinction from 
SGCE-related myoclonus dystonia, the disease course in affected individuals from our 
kindred seems to be non-progressive and no relevant psychiatric disturbances were observed.  
However other features (i.e. childhood-onset, distribution of symptoms in the upper part of 
the body, response to alcohol, and a subcortical origin of myoclonus) partially overlap with 
the clinical phenotype associated with mutations of SGCE, which is generally dominated by 
myoclonus accompanied by mild dystonia.  These findings extend the phenotypic spectrum 
associated with SCN8A to include a movement disorder without seizures or intellectual 
disability. 
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     Figure Legends 
Figure 1. Inheritance of the SCN8A variant P1719R in a family with essential 
myoclonus. (A) Pedigree demonstrating co-inheritance of myoclonus and the SCN8A variant 
(c. 5156C>G, P1719R).  Filled symbols, essential myoclonus. (B) Four-domain structure of 
the voltage-gated sodium channel alpha subunit. P1719R is located in the pore loop of 
domain IV.                           (C) Evolutionary conservation of residue P1719R in multiple 
species. h, human; m, mouse; c, chicken; a, anole; z, zebrafish.  
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Figure 2. The SCN8A variant P1719R results in partial loss of Nav1.6 function.  
(A) Representative traces of sodium currents recorded from ND7/23 cells that were 
transfected with Nav1.6 cDNA. black, wildtype (WT); red, P1719R. (B) Averaged current-
voltage (I-V) relation for WT (black, n=9) and P1719R (red, n=9) channels, and non 
transfected cells (purple, n=12).  (C) Voltage dependence of channel activation. Smooth lines 
correspond to the least squares fit when average data were fit to a single Boltzmann equation. 
(D) Scatter plot of voltage at half-maximal activation (V1/2) for cells expressing WT and 
P1719R channels. (E) Voltage dependence of steady-state inactivation. Smooth lines 
correspond to the least squares fit when average data were fit to a single Boltzmann equation. 
(F) Scatter plot of voltage at half-maximal inactivation (V1/2) for cells expressing WT and 
P1719R channels. 
 
 
 
